Cited by 214Medical Imaging Techniques and ApplicationsRadiomics and Machine Learning in Medical ImagingLung Cancer Diagnosis and Treatment

The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.

Repeatability of SUV in Oncologic 18F-FDG PET

Open access

Lodge, Martin A.·2017·Journal of Nuclear Medicine

DOI 10.2967/jnumed.116.186353PMC PMC5373499

Open this paper in CoChat — free account Open PDF

Abstract

F-FDG PET. Growing literature suggests that the difference between SUVs measured before and after treatment can be used to predict tumor response at an early stage. SUV is, however, associated with multiple sources of variability, and to best use SUV for response assessment, an understanding of the repeatability of the technique is required. Test-retest studies involve repeated scanning of the same patient on the same scanner using the same protocol no more than a few days apart and provide basic information on the repeatability of the technique. Multiple test-retest studies have been performed to assess SUV repeatability, although a comparison of reports is complicated by the use of different methodologies and statistical metrics. This article reviews the available data, addressing issues such as different repeatability metrics, relative units, log transformation, and asymmetric limits of repeatability. When acquired with careful attention to protocol, tumor SUV has a within-subject coefficient of variation of approximately 10%. In a response assessment setting, SUV reductions of more than 25% and increases of more than 33% are unlikely to be due to measurement variability. Broader margins may be required for sites with less rigorous protocol compliance, but in general, SUV is a highly repeatable imaging biomarker that is ideally suited to monitoring tumor response to treatment in individual patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2967/jnumed.116.186353

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Measuring agreement in method comparison studies
Bland, J. M., & Altman, D. G. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800204 · Cited by 9,619
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
Self-citation
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C. E., Sokoloff, L., & Kuhl, D. E. (1979) · Annals of Neurology · doi:10.1002/ana.410060502 · Cited by 2,417
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
Young, H. E., Baum, R. P., Cremerius, U., Herholz, K., Hoekstra, O. S., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,716
SUV: standard uptake or silly useless value?
Keyes, J. W. (1995) · PubMed · Cited by 803
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
Lordick, F., Ott, K., Krause, B., Weber, W., Becker, K., Stein, H. J., Lorenzen, S., Schuster, T., Wieder, H. A., Herrmann, K., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70244-9 · Cited by 801
FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.
Hutchings, M., Loft, A., Hansen, M., Pedersen, L., Buhl, T., Jurlander, J., Buus, S., Keiding, S., d'Amore, F., Boesen, A., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 757
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
Shankar, L. K., Hoffman, J. M., Bacharach, S. L., Graham, M. M., Karp, J. S., Lammertsma, A. A., Larson, S. M., Mankoff, D. A., Siegel, B. A., den Abbeele, A. V., et al. (2006) · PubMed · Cited by 677
A Systematic Review of the Factors Affecting Accuracy of SUV Measurements
Adams, M. C., Turkington, T. G., Wilson, J. M., & Wong, T. Z. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.10.4923 · Cited by 662
Untitled work
(2004) · PubMed · Cited by 653

Show all 47 references

Sorted by citations

Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis
Zwanenburg, A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04391-8 · Cited by 306
Dynamic whole-body PET imaging: principles, potentials and applications
Rahmim, A., Lodge, M. A., Karakatsanis, N. A., Panin, V., Zhou, Y., McMillan, A. B., Cho, S. S., Zaidi, H., Casey, M., & Wahl, R. L. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4153-6 · Cited by 274
Self-citation
An investigation of quantitative accuracy for deep learning based denoising in oncological PET
Lu, W., Onofrey, J. A., Lu, Y., Shi, L., Ma, T., Liu, Y., & Liu, C. (2019) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab3242 · Cited by 130
The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy
Kinahan, P. E., Perlman, E. S., Sunderland, J. J., Subramaniam, R. M., Wollenweber, S. D., Turkington, T. G., Lodge, M. A., Boellaard, R., Obuchowski, N. A., & Wahl, R. L. (2020) · Radiology · doi:10.1148/radiol.2019191882 · Cited by 90
Self-citation
Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors—Initial experience
Tang, S., Meng, M. V., Slater, J. B., Gordon, J. W., Vigneron, D. B., Stohr, B. A., Larson, P. E. Z., & Wang, Z. J. (2021) · Cancer · doi:10.1002/cncr.33554 · Cited by 57
Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 1—Clinical)
Ricard, F., Cheson, B. D., Barrington, S. F., Trotman, J., Schmid, A., Brueggenwerth, G., Salles, G., Schwartz, L., Goldmacher, G., Jarecha, R. R., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264106 · Cited by 54
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
Korde, A. G., Mikołajczak, R., Peitl, P. K., Bouziotis, P., Westin, H., Lauritzen, M., Koole, M. J. B., Herth, M. M., Bardiès, M., Martins, A. F., et al. (2022) · EJNMMI Radiopharmacy and Chemistry · doi:10.1186/s41181-022-00168-x · Cited by 52
Monitoring Response to Therapy
Sathekge, M. M., Ankrah, A. O., Lawal, I. O., & Vorster, M. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.10.004 · Cited by 52
Influences on PET Quantification and Interpretation
Rogasch, J. M. M., Hofheinz, F., van Heek, L., Voltin, C.-A., Boellaard, R., & Kobe, C. (2022) · Diagnostics · doi:10.3390/diagnostics12020451 · Cited by 57
Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners
Viswanath, V., Sari, H., Pantel, A., Conti, M., Daube-Witherspoon, M., Mingels, C., Alberts, I., Eriksson, L., Shi, K., Rominger, A., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05747-3 · Cited by 43
Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer
Silvoniemi, A., Suilamo, S., Laitinen, T., Forsback, S. J., Löyttyniemi, E., Vaittinen, S., Saunavaara, V., Solin, O. H., Grönroos, T. J., & Minn, H. R. I. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3857-3 · Cited by 47
Phase II Trial Assessing the Repeatability and Tumor Uptake of [ 68 Ga]Ga-HER2 Single-Domain Antibody PET/CT in Patients with Breast Carcinoma
Gondry, O., Caveliers, V., Xavier, C., Raes, L., Vanhoeij, M., Verfaillie, G., Fontaine, C., Glorieus, K., Grève, J. D., Joris, S., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266254 · Cited by 46
Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives
Dercle, L., Henry, T., Carré, A., Nikos Paragios, A., Deutsch, É., & Robert, C. (2020) · Methods · doi:10.1016/j.ymeth.2020.07.003 · Cited by 47
Assessing immune organs on 18F-FDG PET/CT imaging for therapy monitoring of immune checkpoint inhibitors: inter-observer variability, prognostic value and evolution during the treatment course of melanoma patients
Prigent, K., Lasnon, C., Ezine, E., Janson, M., Coudrais, N., Joly, E., Césaire, L., Stefan, A., Depontville, M., & Aide, N. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05103-3 · Cited by 46
Toward High-Throughput Artificial Intelligence-Based Segmentation in Oncological PET Imaging
Yousefirizi, F., Jha, A. K., Brosch-Lenz, J., Saboury, B., & Rahmim, A. (2021) · PET Clinics · doi:10.1016/j.cpet.2021.06.001 · Cited by 44
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging
Azad, G. K., Taylor, B. P., Green, A., Sandri, I., Swampillai, A., Harries, M., Kristeleit, H., Mansi, J., Goh, V., & Cook, G. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4223-9 · Cited by 43
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Kolinger, G. D., García, D. V., Kramer, G. M., Frings, V., Smit, E. F., de Langen, A. J., Dierckx, R., Hoekstra, O. S., & Boellaard, R. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0481-1 · Cited by 40
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia
Alberts, I., Sachpekidis, C., Dijkstra, L., Prenosil, G., Gourni, E., Boxler, S., Gross, T., Thalmann, G. N., Rahbar, K., Rominger, A., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04552-9 · Cited by 38
FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls
Cho, S. Y., Huff, D. T., Jeraj, R., & Albertini, M. R. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.06.001 · Cited by 37
Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
Kurland, B. F., Peterson, L. M., Shields, A. T., Lee, J. H., Byrd, D. W., Novakova-Jiresova, A., Muzi, M., Specht, J. M., Mankoff, D. A., Linden, H. M., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.209544 · Cited by 36
The Relationship of BrafV600E Mutation Status to FDG PET/CT Avidity in Thyroid Cancer: A Review and Meta-Analysis
Santhanam, P., Khthir, R. A., Sólnes, L. B., & Ladenson, P. W. (2017) · Endocrine Practice · doi:10.4158/ep-2017-0080 · Cited by 33
Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions
Alberts, I., Sachpekidis, C., Gourni, E., Boxler, S., Gross, T., Thalmann, G. N., Rahbar, K., Rominger, A., & Afshar‐Oromieh, A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04545-8 · Cited by 33
Interpreting Change in Quantitative Imaging Biomarkers
Obuchowski, N. A. (2017) · Academic Radiology · doi:10.1016/j.acra.2017.09.023 · Cited by 32
Statistical evaluation of test-retest studies in PET brain imaging
Baumgartner, R., Joshi, A. D., Feng, D., Zanderigo, F., & Ogden, R. T. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0366-8 · Cited by 32
Quantitative Test–Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue
Pollard, J. H., Raman, C., Zakharia, Y., Tracy, C. R., Nepple, K. G., Ginader, T., Breheny, P. J., & Sunderland, J. J. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.236083 · Cited by 32
Role of 18F-FDG PET/CT Radiomics Features in the Differential Diagnosis of Solitary Pulmonary Nodules: Diagnostic Accuracy and Comparison between Two Different PET/CT Scanners
Albano, D., Gatta, R., Marini, M., Rodella, C. A., Camoni, L., Dondi, F., Giubbini, R., & Bertagna, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215064 · Cited by 32
SUV variability in EARL-accredited conventional and digital PET
Koopman, D., Jager, P. L., Slump, C. H., Knollema, S., & van Dalen, J. A. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0569-7 · Cited by 31
Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients
Tosi, D., Pieropan, S., Cattoni, M., Bonitta, G., Franzi, S., Mendogni, P., Imperatori, A. S., Rotolo, N., Castellani, M., Cuzzocrea, M., et al. (2021) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003714 · Cited by 31
Background parenchymal enhancement and uptake as breast cancer imaging biomarkers: A state-of-the-art review
Bauer, E., Levy, M. S., Domachevsky, L., Anaby, D., & Nissan, N. (2021) · Clinical Imaging · doi:10.1016/j.clinimag.2021.11.021 · Cited by 31
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
Vargas, H. A., Kramer, G. M., Scott, A. M., Weickhardt, A. J., Meier, A. A., Parada, N. A., Beattie, B. J., Humm, J. L., Staton, K. D., ZANZONICO, P. B., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.206490 · Cited by 31
Multicentre analysis of PET SUV using vendor-neutral software: the Japanese Harmonization Technology (J-Hart) study
J-Hart study group, Tsutsui, Y., Daisaki, H., Akamatsu, G., Umeda, T., Ogawa, M., Kajiwara, H., Kawase, S., Sakurai, M., Nishida, H., et al. (2018) · EJNMMI Research · doi:10.1186/s13550-018-0438-9 · Cited by 29
PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma
Kobe, C., Dietlein, M., & Hellwig, D. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.09.003 · Cited by 28
Variability and Repeatability of Quantitative Uptake Metrics in 18 F-FDG PET/CT of Non–Small Cell Lung Cancer: Impact of Segmentation Method, Uptake Interval, and Reconstruction Protocol
Zhuang, M., García, D. V., Kramer, G. M., Frings, V., Smit, E. F., Dierckx, R., Hoekstra, O. S., & Boellaard, R. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.216028 · Cited by 28
Repeatability of Quantitative Brown Adipose Tissue Imaging Metrics on Positron Emission Tomography with 18F-Fluorodeoxyglucose in Humans
Fraum, T. J., Crandall, J. P., Ludwig, D. R., Chen, S., Fowler, K. J., Laforest, R. A., Salter, A. R., Dehdashti, F., An, H., & Wahl, R. L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.05.019 · Cited by 28
Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
Alhuseinalkhudhur, A., Lubberink, M., Lindman, H., Максимилианович, Т. В., Frejd, F. Y., Feldwisch, J., Velikyan, I., & Sörensen, J. (2020) · EJNMMI Research · doi:10.1186/s13550-020-0603-9 · Cited by 25
Repeated social defeat induces transient glial activation and brain hypometabolism: A positron emission tomography imaging study
Feltes, P. K., de Vries, E. F. J., Juárez‐Orozco, L. E., Kurtys, E., Dierckx, R., Jeckel, C. M. M., & Doorduin, J. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17747189 · Cited by 24
Measurement Repeatability of18F-FDG PET/CT Versus18F-FDG PET/MRI in Solid Tumors of the Pelvis
Fraum, T. J., Fowler, K. J., Crandall, J. P., Laforest, R. A., Salter, A. R., An, H., Jacobs, M. A., Grigsby, P. W., Dehdashti, F., & Wahl, R. L. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.218735 · Cited by 24
Repeatability of 18F-FDG PET Radiomic Features in Cervical Cancer
Crandall, J. P., Fraum, T. J., Lee, M., Jiang, L., Grigsby, P. W., & Wahl, R. L. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.247999 · Cited by 24
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting
Colleran, G., Kwatra, N. S., Oberg, L., Grant, F. D., Drubach, L. A., Callahan, M. J., MacDougall, R. D., Fahey, F. H., & Voss, S. D. (2017) · Cancer Imaging · doi:10.1186/s40644-017-0130-8 · Cited by 24
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake
Sahakyan, K., Li, X., Lodge, M. A., Werner, R. A., Bundschuh, R. A., Bundschuh, L., Kulkarni, H., Schuchardt, C., Baum, R. P., Pienta, K. J., et al. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01376-9 · Cited by 23
Self-citation
Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapy
Akaike, K., Saruwatari, K., Oda, S., Shiraishi, S., Takahashi, H., Hamada, S., Iyama, S., Horio, Y., Tomita, Y., Saeki, S., et al. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01584-x · Cited by 23
Uptake of Radium-223 Dichloride and Early [18F]NaF PET Response Are Driven by Baseline [18F]NaF Parameters: a Pilot Study in Castration-Resistant Prostate Cancer Patients
Letellier, A., Johnson, A. C., Kit, N. H., Savigny, J.-F., Batalla, A., Parienti, J., & Aide, N. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1132-4 · Cited by 23
Chemoradiotherapy for locally advanced cervix cancer without aortic lymph node involvement: can we consider metabolic parameters of pretherapeutic FDG-PET/CT for treatment tailoring?
Voglimacci, M., Gabiache, E., Lusque, A., Ferron, G., Ducassou, A., Querleu, D., Motton, S., Chantalat, É., Courbon, F., & Martínez, A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4219-5 · Cited by 23
A systematic review on the use of quantitative imaging to detect cancer therapy adverse effects in normal-appearing brain tissue
Petr, J., Hogeboom, L., Nikulin, P., Wiegers, E. C., Schroyen, G., Kallehauge, J. F., Chmelík, M., Clement, P., Nechifor, R. E., Fodor, L. A., et al. (2021) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-021-00985-2 · Cited by 26
Bone marrow segmentation and radiomics analysis of [18F]FDG PET/CT images for measurable residual disease assessment in multiple myeloma
Milara, E., Gómez‐Grande, A., Tomás-Soler, S., Seiffert, A. P., Alonso, R., Aguilera, E. J. G., Martínez‐López, J., & González, P. S. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107083 · Cited by 22
Commissioning of a novel PET‐Linac for biology‐guided radiotherapy (BgRT)
Sürücü, M., Ashraf, M. R., Romero, I. O., Zalavari, L. T., Pham, D., Vitzthum, L. K., Gensheimer, M. F., Yang, Y., Xing, L., Kovalchuk, N., et al. (2024) · Medical Physics · doi:10.1002/mp.17114 · Cited by 22
Repeatability of brown adipose tissue measurements on FDG PET/CT following a simple cooling procedure for BAT activation
Crandall, J. P., Gajwani, P., Joo Hyun, O., Mawhinney, D. D., Sterzer, F., & Wahl, R. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214765 · Cited by 21
Multicenter study of quantitative PET system harmonization using NIST-traceable 68Ge/68Ga cross-calibration kit
Miwa, K., Wagatsuma, K., Iimori, T., Sawada, K., Kamiya, T., Sakurai, M., Miyaji, N., Murata, T., & Sato, E. (2018) · Physica Medica · doi:10.1016/j.ejmp.2018.07.001 · Cited by 20
Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [ 1‐13C ] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade
Chowdhury, R., Mueller, C. A., Smith, L. A., Gong, F., Papoutsaki, M., Rogers, H. J., Syer, T., Singh, S., Brembilla, G., Retter, A., et al. (2022) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.28467 · Cited by 20
Comparison between Two Different Scanners for the Evaluation of the Role of 18F-FDG PET/CT Semiquantitative Parameters and Radiomics Features in the Prediction of Final Diagnosis of Thyroid Incidentalomas
Dondi, F., Pasinetti, N., Gatta, R., Albano, D., Giubbini, R., & Bertagna, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030615 · Cited by 20
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer
Aide, N., Fauchille, P., Coquan, E., Ferron, G., Combe, P., Meunier, J., Alexandre, J., Berton, D., Leary, A. F., Rauglaudre, G. D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05092-3 · Cited by 19
Method to determine the statistical technical variability of SUV metrics
Luca, G. D. D., & Habraken, J. (2022) · EJNMMI Physics · doi:10.1186/s40658-022-00470-2 · Cited by 19
Measurement Variability in Treatment Response Determination for Non–Small Cell Lung Cancer
Lee, G., Bak, S. H., Lee, H. Y., Choi, J. Y., Park, H., Lee, S.-H., Ohno, Y., Nishino, M., van Beek, E. J. R., & Lee, K. S. (2019) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000390 · Cited by 19
Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
Jauw, Y. W. S., Heijtel, D., Zijlstra, J. M., Hoekstra, O. S., de Vet, H. C. W., Vugts, D. J., Verheul, H. M. W., Boellaard, R., Zweegman, S., van Dongen, G. A. M. S., et al. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-018-1200-4 · Cited by 18
CMBD: a manually curated cancer metabolic biomarker knowledge database
Chen, J., Liu, X., Shen, L., Lin, Y., & Shen, B. (2020) · Database · doi:10.1093/database/baaa094 · Cited by 18
Accurate total‐body Ki parametric imaging with shortened dynamic 18F‐FDG PET scan durations via effective data processing
Chen, Z., Cheng, Z., Duan, Y., Zhang, Q., Zhang, N., Gu, F., Wang, Y., Zhou, Y., Wang, H., Liang, D., et al. (2022) · Medical Physics · doi:10.1002/mp.15893 · Cited by 17
Repeatability of deuterium metabolic imaging of healthy volunteers at 3 T
Bøgh, N., Væggemose, M., Schulte, R. F., Hansen, E. S. S., & Laustsen, C. (2024) · European Radiology Experimental · doi:10.1186/s41747-024-00426-4 · Cited by 17
Test–retest repeatability of quantitative bone SPECT/CT
Yamane, T., Fukushima, K., Shirotake, S., Nishimoto, K., Okabe, T., Oyama, M., Seto, A., & Kuji, I. (2021) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01568-2 · Cited by 17
SUV Harmonization Between Different Hybrid PET/CT Systems
Rubello, D., & Colletti, P. M. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002284 · Cited by 16
Positron emission tomography and magnetic resonance imaging in experimental human malaria to identify organ-specific changes in morphology and glucose metabolism: A prospective cohort study
Woodford, J., Gillman, A., Jenvey, P., Roberts, J., Woolley, S., Barber, B. E., Fernandez, M., Rose, S., Thomas, P. A., Anstey, N. M., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003567 · Cited by 16
A proper protocol for routine 18F-FDG uEXPLORER total-body PET/CT scans
Hu, H., Huang, Y., Sun, H., Zhou, K., Jiang, L., Zhong, J., Chen, L., Wang, L., Han, Y., & Wu, H. (2023) · EJNMMI Physics · doi:10.1186/s40658-023-00573-4 · Cited by 16
Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome
Angkasekwinai, N., Suputtamongkol, Y., Tantibhedhyangkul, W., Onlamoon, N., Phoompoung, P., Pithukpakorn, M., Karuphong, E., Pusuwan, P., & Angkasekwinai, P. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad676 · Cited by 15
Quantitative PET/CT in clinical practice
Mhlanga, J. C., Chirindel, A., Lodge, M. A., Wahl, R. L., & Subramaniam, R. M. (2017) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000786 · Cited by 15
Self-citation
How to harmonize SUVs obtained by hybrid PET/CT scanners with and without point spread function correction
Ferretti, A., Chondrogiannis, S., Rampin, L., Bellan, E., Marzola, M. C., Grassetto, G., Gusella, S., Maffione, A. M., Gava, M. M., & Rubello, D. (2018) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aaee27 · Cited by 15
Are lesion features reproducible between 18F-FDG PET/CT images when acquired on analog or digital PET/CT scanners?
Constantino, C. S., Oliveira, F. P. M., Silva, M., Oliveira, C., Castanheira, J. C., Silva, Â., Vaz, S. C., Vieira, P. M., & Costa, D. C. (2020) · European Radiology · doi:10.1007/s00330-020-07390-8 · Cited by 15
Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study
Monsef, A., Ay, M., Sheikhzadeh, P., Geramifar, P., Rahmim, A., & Ghafarian, P. (2022) · Nuclear medicine communications · doi:10.1097/mnm.0000000000001598 · Cited by 11
Statistical considerations for repeatability and reproducibility of quantitative imaging biomarkers
Ye, S., Lim, J. Y., & Huang, W. (2022) · BJR|Open · doi:10.1259/bjro.20210083 · Cited by 14
Integrating Imaging and Circulating Tumor DNA Features for Predicting Patient Outcomes
Magbanua, M. J. M., Li, W., & Veer, L. V. ‘. (2024) · Cancers · doi:10.3390/cancers16101879 · Cited by 14
Establishment of a method for in-vivo SPECT/CT imaging analysis of 111In-labeled exendin-4 pancreatic uptake in mice without the need for nephrectomy or a secondary probe
Hamamatsu, K., Fujimoto, H., Fujita, N., Murakami, T., Kimura, H., Saji, H., & Inagaki, N. (2018) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2018.06.002 · Cited by 14
The Elusive Link Between Cancer FDG Uptake and Glycolytic Flux Explains the Preserved Diagnostic Accuracy of PET/CT in Diabetes
Cossu, V., Bauckneht, M., Bruno, S., Orengo, A. M., Emionite, L., Balza, E., Castellani, P., Piccioli, P., Miceli, A., Raffa, S., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100752 · Cited by 14
Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy
Oriuchi, N., Sugawara, S., & Shiga, T. (2020) · Biomedicines · doi:10.3390/biomedicines8090371 · Cited by 15
Day-to-day variability of [68Ga]Ga-PSMA-11 accumulation in primary prostate cancer: effects on tracer uptake and visual interpretation
Heuvel, J. O., der Veen, B. J. D. W., Donswijk, M. L., Slump, C. H., & Stokkel, M. P. M. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00708-z · Cited by 14
Evaluation of Quantitative Ga-68 PSMA PET/CT Repeatability of Recurrent Prostate Cancer Lesions Using Both OSEM and Bayesian Penalized Likelihood Reconstruction Algorithms
Roef, M., Rijnsdorp, S., Brouwer, C., Wyndaele, D., & Arends, A. (2021) · Diagnostics · doi:10.3390/diagnostics11061100 · Cited by 11
Standardisation of conventional and advanced iterative reconstruction methods for Gallium-68 multi-centre PET-CT trials
Krokos, G., Pike, L. C., Cook, G., & Marsden, P. K. (2021) · EJNMMI Physics · doi:10.1186/s40658-021-00400-8 · Cited by 15
Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management
Shaikh, M. S., Kurhade, R. R., Siddiqui, A., Majeed, S. S. A., Webster, T. J., Alam, M. I., Zia, A. W., & Faiyazuddin, M. (2025) · ChemBioChem · doi:10.1002/cbic.202500676 · Cited by 13
Quality Assessment in FDG-PET/CT Imaging of Head-and-Neck Cancer: One Home Run Is Better Than Two Doubles
WYNGAERT, T. V. D., Schepper, S. D., & Carp, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01458 · Cited by 13
High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL
Werner, R. A., Habacha, B., Lütje, S., Bundschuh, L., Higuchi, T., Hartrampf, P. E., Serfling, S. E., Derlin, T., Lapa, C., Buck, A. K., et al. (2022) · Molecular Imaging · doi:10.1155/2022/7056983 · Cited by 13
Self-citation
PET/CT in Pediatric Oncology
States, L. J., & Voss, S. D. (2019) · Pediatric oncology · doi:10.1007/978-3-030-03777-2_3 · Cited by 13
Relationship between tumor mutational burden and maximum standardized uptake value in 2-[18F]FDG PET (positron emission tomography) scan in cancer patients
Jahromi, A. H., Barkauskas, D. A., Zabel, M. K., Goodman, A. M., Frampton, G. M., Nikanjam, M., Hoh, C. K., & Kurzrock, R. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00732-z · Cited by 13
Improved image reconstruction of 89Zr-immunoPET studies using a Bayesian penalized likelihood reconstruction algorithm
Kirchner, J., O’Donoghue, J. A., Becker, A. S., & Ulaner, G. A. (2021) · EJNMMI Physics · doi:10.1186/s40658-021-00352-z · Cited by 13
Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome
Lokre, O., Perk, T., Weisman, A., Govindan, R., Chen, S., Chen, M., Eickhoff, J., Liu, G., & Jeraj, R. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06764-0 · Cited by 11
Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN
Ma, K. C., Mena, E., Lindenberg, L., Lay, N. S., Eclarinal, P., Citrin, D., Pinto, P. A., Wood, B. J., Dahut, W., Gulley, J., et al. (2024) · OncoTarget · doi:10.18632/oncotarget.28583 · Cited by 11
Metabolic Profiling Techniques and Their Application in Cancer Research
Alwahsh, M., Abumansour, H., Althaher, A. R., & Hergenröder, R. (2024) · Current Pharmaceutical Analysis · doi:10.2174/0115734129317614240809053901 · Cited by 11
Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis
Kramer, G. M., Liu, Y., Langen, A. J. D., Jansma, E. P., Trigonis, I., Asselin, M., Jackson, A., Kenny, L. M., Aboagye, E. O., Hoekstra, O. S., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3923-x · Cited by 11
Co-Clinical Imaging Resource Program (CIRP): Bridging the Translational Divide to Advance Precision Medicine
Shoghi, K. I., Badea, C. T., Blocker, S. J., Chenevert, T. L., Laforest, R. A., Lewis, M. T., Luker, G. D., Manning, H. C., Marcus, D. S., Mowery, Y. M., et al. (2020) · Tomography · doi:10.18383/j.tom.2020.00023 · Cited by 11
Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging
Mannheim, J. G., Cheng, J.-C. K., Vafai, N. M., Shahinfard, E., English, C., McKenzie, J., Zhang, J., Barlow, L. R., & Sossi, V. (2021) · EJNMMI Physics · doi:10.1186/s40658-020-00349-0 · Cited by 11
Intra- and Interobserver Agreement of SUV SPECT Quantitative SPECT/CT Processing Software, Applied in Clinical Settings for Patients with Solid Renal Tumors
Tzortzakakis, A., Holstensson, M., Hagel, E., Karlsson, M., & Axelsson, R. (2019) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.118.223297 · Cited by 11
Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer
Cysouw, M. C. F., Kramer, G. M., Heijtel, D., Schuit, R. C., Morris, M. J., van den Eertwegh, A. J. M., Voortman, J., Hoekstra, O. S., Oprea‐Lager, D. E., & Boellaard, R. (2019) · EJNMMI Research · doi:10.1186/s13550-019-0531-8 · Cited by 11
Prognostic value of [ 18 F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience
Ventura, L., Scarlattei, M., Gnetti, L., Silini, E. M., Rossi, M., Tiseo, M., Sverzellati, N., Bocchialini, G., Musini, L., Balestra, V., et al. (2020) · Tumori Journal · doi:10.1177/0300891620904404 · Cited by 11
Measurement of PET Quantitative Bias In Vivo
Lodge, M. A., Lesniak, W. G., Gorin, M. A., Pienta, K. J., Rowe, S. P., & Pomper, M. G. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.251397 · Cited by 11
Self-citation
Standardized uptake value of normal organs on routine clinical [18F]FDG PET/CT: impact of tumor metabolism and patient-related factors
Sharma, P., Chatterjee, P., Alvarado, L. A., & Dwivedi, A. K. (2022) · Nuclear Medicine Review · doi:10.5603/nmr.a2022.0036 · Cited by 10
Prospective inter- and intra-tracer repeatability analysis of radiomics features in [68Ga]Ga-PSMA-11 and [18F]F-PSMA-1007 PET scans in metastatic prostate cancer
Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., Jeraj, R., Barry, N., Hagan, T., & Ebert, M. A. (2023) · British Journal of Radiology · doi:10.1259/bjr.20221178 · Cited by 10
Leveraging machine learning with dynamic 18F-FDG PET/CT: integrating metabolic and flow features for lung cancer differential diagnosis
Yao, Z., Wang, Y., Wu, Y., Zhou, J., Dang, N., Wang, M., Liang, Y., & Sun, T. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07231-0 · Cited by 10
Repeatability of Quantitative 18F-FET PET in Glioblastoma
Ferjančič, P., Ebert, M. A., Francis, R. J., Nowak, A. K., & Jeraj, R. (2021) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/abfae9 · Cited by 10
Improved Clinical Workflow for Whole-Body Patlak Parametric Imaging Using Two Short Dynamic Acquisitions
Wang, H., Miao, Y., Yu, W., Zhu, G., Wu, T., Zhao, X., Yuan, G., Li, B., & Xu, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.822708 · Cited by 10
Impact of free-breathing CT on quantitative measurements of static and quiescent period-gated PET Images
Meier, J. G., Einstein, S. A., Diab, R. H., Erasmus, L. J., Xu, G., & Mawlawi, O. R. (2019) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ab1cdd · Cited by 10
Positron-emission tomography-guided radiation therapy: Ongoing projects and future hopes
Giraud, N., Popinat, G., Regaieg, H., Tonnelet, D., & Véra, P. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.02.009 · Cited by 10
Impact of Aggregation Methods for Texture Features on Their Robustness Performance: Application to Nasopharyngeal 18F-FDG PET/CT
Peng, L., Xu, H., Lv, W., Lu, L., & Chen, W. (2023) · Cancers · doi:10.3390/cancers15030932 · Cited by 9
Evaluation of Data-Driven Respiration Gating in Continuous Bed Motion in Lung Lesions
Nii, T., Hosokawa, S., Kotani, T., Domoto, H., Nakamura, Y., Tanada, Y., Kondo, R., & Takahashi, Y. (2023) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.122.264909 · Cited by 9
Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET/CT protocol in patients with metastatic melanoma treated by immunotherapy
Pavoine, M., Thuillier, P., Karakatsanis, N. A., Legoupil, D., Amrane, K., Floch, R., Pennec, R. L., Salaün, P.-Y., Abgral, R., & Bourhis, D. (2023) · EJNMMI Physics · doi:10.1186/s40658-023-00601-3 · Cited by 7

Authors: Lodge, M. A.
Affiliations: Johns Hopkins University (US)
Corresponding author: Lodge, Martin A.
ORCID: Lodge, Martin A.
Venue: Journal of Nuclear Medicine
Publisher: Society of Nuclear Medicine
Published: 2017-02-23
Volume: 58
Issue: 4
Pages: 523-532
ISSN: 0161-5505 (ISSN-L)
2159-662X
DOI: 10.2967/jnumed.116.186353
PMC: PMC5373499
OpenAlex: W2590848133
Cited by: 214
References: 47
Citations by year: 2026: 26 · 2025: 21 · 2024: 31 · 2023: 14 · 2022: 18 · 2021: 23 · 2020: 23 · 2019: 23 · 2018: 21 · 2017: 14
FWCI: 3.35
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Nuclear Medicine (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Radiological Society of North America (HHSN268201300071C)
Society of Nuclear Medicine and Molecular Imaging
National Institutes of Health (HHSN268201300071C)
National Cancer Institute (U01CA140204)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
Keywords: standardized uptake value, 18F-FDG PET, test-retest repeatability, tumor response assessment, within-subject coefficient of variation, imaging biomarkers, treatment response monitoring, logarithmic transformation, tumor imaging
MeSH terms: Biological Transport, Humans, Neoplasms, Reproducibility of Results, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Repeatability of SUV in Oncologic 18F-FDG PET

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks